Ma Xuân Thành

Main Article Content

Abstract

A 15-mer cationic α-helical antibacterial peptide was used as the framework to study the effect of peptide secondary structure on antimicrobial activities. We designed an α-helical peptide with higher helical propensity compared with the original peptide, a β-sheet peptide and a random coiled peptide without changing the original amino acid composition of the peptide sequence. Three truncated peptides were also designed. The secondary structures of the peptides were determined by circular dichroism spectra both in aqueous solution and in hydrophobic environment. The biological activities of the peptides were detected against three Gram-negative bacterial strains, three Gram-positive bacterial strains and human red blood cells. The results showed that the two helical peptides exhibited comparable antibacterial activities but their hemolytic potency (cytotoxicity) varied from extreme hemolysis to no hemolysis, which was positively correlated with their helical propensity. The β-sheet peptide partially lost both of the biological activities. The random coiled peptide with the lowest improvement in hemolytic activity showed comparable antibacterial activity against Gram-positive bacteria but weaker antibacterial activity against Gram-negative bacteria. Truncated peptides showed inevitable weaker antimicrobial activity compared to the parent peptide. Our results show that peptide secondary structure is strongly correlated with hemolytic activity and relatively less correlated with antimicrobial activity, which provides an insight into the mechanism of action of the antimicrobial peptide.

Keywords: Antimicrobial peptide, secondary structure, specificity, mechanism of action.

References

[1] Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrobial agents and chemotherapy 2007;51: 1398-406.
[2] Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. The Journal of biological chemistry 2005;280:12316-29.
[3] Brouwer CP, Wulferink M, Welling MM. The pharmacology of radiolabeled cationic antimicrobial peptides. Journal of pharmaceutical sciences 2008;97:1633-51.
[4] Sato H, Feix JB. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochimica et biophysica acta 2006;1758:1245-56.
[5] Dubovskii PV, Volynsky PE, Polyansky AA, Chupin VV, Efremov RG, Arseniev AS. Spatial structure and activity mechanism of a novel spider antimicrobial peptide. Biochemistry 2006;45:10759-67.
[6] McPhee JB, Hancock RE. Function and therapeutic potential of host defence peptides. Journal of peptide science: an official publication of the European Peptide Society 2005;11:677-87.
[7] Wang X, Zheng Y, Xu Y, Ben J, Gao S, Zhu X, et al. A novel peptide binding to the cytoplasmic domain of class A scavenger receptor reduces lipid uptake in THP-1 macrophages. Biochimica et biophysica acta 2009;1791:76-83.
[8] Lockwood NA, Haseman JR, Tirrell MV, Mayo KH. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. The Biochemical journal 2004;378:93-103.
[9] Weng C. Chan PDW. Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford: Oxford University Press; 2000. p. 346.
[10] [Chen Y, Mant CT, Hodges RS. Temperature selectivity effects in reversed-phase liquid chromatography due to conformation differences between helical and non-helical peptides. Journal of Chromatography A 2003;1010:45-61.
[11] Chen Y, Vasil AI, Rehaume L, Mant CT, Burns JL, Vasil ML, et al. Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chemical biology & drug design 2006;67:162-73.
[12] Park SC, Kim MH, Hossain MA, Shin SY, Kim Y, Stella L, et al. Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Biochimica et biophysica acta 2008;1778:229-41.
[13] Hancock RE. Peptide antibiotics. Lancet1997;349: 418–422.
[14] Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006;19:491–511.
[15] Pouny Y, Shai Y. Interaction of D-amino acid incorporated analogues of pardaxin with membranes. Biochemistry1992;31: 9482–9490.
[16] DatheM, SchumannM, Wieprecht T, Winkler A, BeyermannM, Krause E, Matsuzaki K, Murase O, Bienert M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 1996;35: 12612–12622.